Pulsed Electromagnetic Field Stimulation in Osteogenesis and Chondrogenesis: Signaling Pathways and Therapeutic Implications.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
15 Jan 2021
Historique:
received: 02 12 2020
revised: 30 12 2020
accepted: 11 01 2021
entrez: 20 1 2021
pubmed: 21 1 2021
medline: 13 4 2021
Statut: epublish

Résumé

Mesenchymal stem cells (MSCs) are the main cell players in tissue repair and thanks to their self-renewal and multi-lineage differentiation capabilities, they gained significant attention as cell source for tissue engineering (TE) approaches aimed at restoring bone and cartilage defects. Despite significant progress, their therapeutic application remains debated: the TE construct often fails to completely restore the biomechanical properties of the native tissue, leading to poor clinical outcomes in the long term. Pulsed electromagnetic fields (PEMFs) are currently used as a safe and non-invasive treatment to enhance bone healing and to provide joint protection. PEMFs enhance both osteogenic and chondrogenic differentiation of MSCs. Here, we provide extensive review of the signaling pathways modulated by PEMFs during MSCs osteogenic and chondrogenic differentiation. Particular attention has been given to the PEMF-mediated activation of the adenosine signaling and their regulation of the inflammatory response as key player in TE approaches. Overall, the application of PEMFs in tissue repair is foreseen: (1) in vitro: to improve the functional and mechanical properties of the engineered construct; (2) in vivo: (i) to favor graft integration, (ii) to control the local inflammatory response, and (iii) to foster tissue repair from both implanted and resident MSCs cells.

Identifiants

pubmed: 33467447
pii: ijms22020809
doi: 10.3390/ijms22020809
pmc: PMC7830993
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Références

Biotechnol Bioeng. 2020 May;117(5):1584-1596
pubmed: 31985051
Int Orthop. 2019 Mar;43(3):539-551
pubmed: 30645684
Biochem Biophys Res Commun. 2018 Sep 5;503(2):715-721
pubmed: 29909008
Sci Rep. 2018 Mar 23;8(1):5108
pubmed: 29572540
Science. 1974 May 3;184(4136):575-7
pubmed: 4821958
Stem Cells. 2006 Jul;24(7):1707-18
pubmed: 16574750
Lancet. 2015 Jul 25;386(9991):376-87
pubmed: 25748615
J Biomed Nanotechnol. 2018 Dec 1;14(12):2135-2145
pubmed: 30305220
J Cell Physiol. 2016 Sep;231(9):1852-61
pubmed: 26754327
Front Cell Dev Biol. 2019 Nov 12;7:268
pubmed: 31799249
Tissue Cell. 2018 Feb;50:1-7
pubmed: 29429509
Stem Cell Rev Rep. 2020 Oct;16(5):1005-1012
pubmed: 32681233
Electromagn Biol Med. 2019;38(1):1-20
pubmed: 30661411
Osteoarthritis Cartilage. 2004 May;12(5):349-59
pubmed: 15094133
Br J Pharmacol. 2010 May;160(1):101-15
pubmed: 20331607
NPJ Regen Med. 2017 Dec 15;2:32
pubmed: 29302365
Int J Mol Sci. 2015 Aug 07;16(8):18412-38
pubmed: 26262612
Sci Rep. 2017 Aug 25;7(1):9421
pubmed: 28842627
Bioelectromagnetics. 2011 May;32(4):283-90
pubmed: 21452358
J Immunol. 2015 Mar 15;194(6):2487-92
pubmed: 25681339
Stem Cell Res Ther. 2018 May 21;9(1):143
pubmed: 29784011
J Tissue Eng Regen Med. 2015 Dec;9(12):E229-38
pubmed: 23255506
BMC Musculoskelet Disord. 2013 Jan 19;14:35
pubmed: 23331333
Osteoarthritis Cartilage. 2016 Aug;24(8):1307-16
pubmed: 26973328
Cell Prolif. 2019 Jul;52(4):e12623
pubmed: 31115100
Bioelectromagnetics. 2014 Sep;35(6):426-36
pubmed: 25099126
J Cell Physiol. 2012 Jun;227(6):2461-9
pubmed: 21830213
Osteoarthritis Cartilage. 2009 Feb;17(2):252-62
pubmed: 18640059
J Orthop Res. 2020 Nov;38(11):2350-2361
pubmed: 32141629
Arthritis Rheum. 2009 Oct;60(10):3061-71
pubmed: 19790055
J Tissue Eng Regen Med. 2018 Feb;12(2):304-315
pubmed: 28482141
Injury. 2003 May;34(5):357-62
pubmed: 12719164
Stem Cell Res Ther. 2020 Feb 3;11(1):46
pubmed: 32014064
Stem Cells Int. 2020 Jul 15;2020:9529465
pubmed: 32733574
Acta Biomater. 2021 Jan 1;119:169-183
pubmed: 33130304
Bone. 2020 Sep;138:115491
pubmed: 32569871
Trends Pharmacol Sci. 2016 Jun;37(6):419-434
pubmed: 26944097
J Cell Mol Med. 2013 Aug;17(8):958-65
pubmed: 23802593
Mediators Inflamm. 2017;2017:2740963
pubmed: 28255202
Cells Tissues Organs. 2017;204(2):59-83
pubmed: 28647733
Science. 1999 Apr 2;284(5411):143-7
pubmed: 10102814
J Intern Med. 2009 Oct;266(4):390-405
pubmed: 19765182
In Vivo. 2013 Jul-Aug;27(4):495-500
pubmed: 23812219
Bioelectromagnetics. 2017 Jan;38(1):63-77
pubmed: 27859405
Sci Rep. 2015 Sep 14;5:13856
pubmed: 26364969
J Cell Physiol. 2018 Apr;233(4):2937-2948
pubmed: 28590066
Trends Endocrinol Metab. 2013 Jun;24(6):290-300
pubmed: 23499155
Stem Cells Int. 2018 Jul 12;2018:5402853
pubmed: 30123287
Biochem Pharmacol. 2020 Apr;174:113784
pubmed: 31884043
Osteoarthritis Cartilage. 2008 Mar;16(3):292-304
pubmed: 17698373
Curr Stem Cell Res Ther. 2010 Jun;5(2):103-10
pubmed: 19941460
Br J Pharmacol. 2002 May;136(1):57-66
pubmed: 11976268
Physiol Rev. 2018 Jul 1;98(3):1591-1625
pubmed: 29848236
Artif Organs. 2016 Oct;40(10):929-937
pubmed: 27086585
J Appl Physiol (1985). 2013 Mar 1;114(5):647-55
pubmed: 23239875
Stem Cells Int. 2015;2015:895714
pubmed: 26273307
J Cell Physiol. 2018 Mar;233(3):2645-2656
pubmed: 28786478
Ann Palliat Med. 2020 Sep 22;:
pubmed: 33040558
Science. 1962 Sep 28;137(3535):1063-4
pubmed: 13865637
Nat Commun. 2017 May 11;8:15019
pubmed: 28492224
Bioelectromagnetics. 2015 Oct;36(7):494-505
pubmed: 26364557
J Orthop Res. 2008 Sep;26(9):1250-5
pubmed: 18404656
BMC Musculoskelet Disord. 2015 Sep 02;16:233
pubmed: 26328626
Bioact Mater. 2020 Sep 21;6(3):666-683
pubmed: 33005830
BMC Musculoskelet Disord. 2015 Oct 20;16:308
pubmed: 26480822
J Mol Med (Berl). 2018 Oct;96(10):1049-1060
pubmed: 30088034
J Biomed Mater Res A. 2014 May;102(5):1558-67
pubmed: 23775982
Int J Immunopathol Pharmacol. 2011 Jan-Mar;24(1 Suppl 2):1-6
pubmed: 21669129
Bioelectromagnetics. 2020 May;41(4):263-278
pubmed: 32159242
Mol Cell Biochem. 2009 Jan;321(1-2):135-43
pubmed: 18836817
Int J Mol Sci. 2020 Mar 19;21(6):
pubmed: 32204349
J Cell Physiol. 2011 May;226(5):1353-66
pubmed: 20945394
PLoS One. 2018 Jun 14;13(6):e0199046
pubmed: 29902240
Br J Pharmacol. 2017 Jul;174(13):1945-1960
pubmed: 28252203
PLoS One. 2013 May 31;8(5):e65561
pubmed: 23741498
Bioelectromagnetics. 2015 Jan;36(1):35-44
pubmed: 25358461
Front Cell Dev Biol. 2016 May 06;4:40
pubmed: 27200351

Auteurs

Katia Varani (K)

Department of Translational Medicine and for Romagna, University of Ferrara, 44121 Ferrara, Italy.

Fabrizio Vincenzi (F)

Department of Translational Medicine and for Romagna, University of Ferrara, 44121 Ferrara, Italy.

Silvia Pasquini (S)

Department of Translational Medicine and for Romagna, University of Ferrara, 44121 Ferrara, Italy.

Irene Blo (I)

Department of Medical Sciences, University of Ferrara, 44121 Ferrara, Italy.

Simona Salati (S)

IGEA SpA, Clinical Biophysiscs, 41012 Carpi, Italy.

Matteo Cadossi (M)

IGEA SpA, Clinical Biophysiscs, 41012 Carpi, Italy.

Monica De Mattei (M)

Department of Medical Sciences, University of Ferrara, 44121 Ferrara, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH